[{"Assets_0_Q2_USD":684753000.0,"CommonStockSharesOutstanding_0_Q2_shares":56529398.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":90428000.0,"NetIncomeLoss_1_Q2_USD":-16034000.0,"NetIncomeLoss_2_Q2_USD":64012000.0,"StockholdersEquity_0_Q2_USD":608091000.0,"EarningsPerShareBasic_1_Q2_USD":-0.28,"EarningsPerShareBasic_2_Q2_USD":1.14,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":56399255.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":56351377.0,"Ticker":"XNCR","CIK":"1326732","name":"XENCOR INC","OfficialName":"Xencor Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1574633486.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]